Cogmedix, a wholly owned subsidiary of Coghlin Companies Inc., established in 1885, is proud to announce that Medizone International, Inc., (OTCQB: MZEI) has selected Cogmedix as their turnkey medical device manufacturing services provider for the AsepticSure® Generation III hospital disinfection system.
This partnership is the culmination of months of collaboration. Medizone Chairman and CEO, Edwin Marshall, was elated with this milestone and stated, “In Cogmedix we have contracted with a seasoned FDA medical device manufacturer with a depth of supply chain resources and the expertise to ensure the highest quality product is delivered, while also carefully controlling manufacturing costs. We’re convinced Cogmedix will enable us to meet significant increases in product demand as we enter the US market and also serve manufacturing requirements for international markets as AsepticSure® puts an end to environmentally caused hospital-acquired infection worldwide.”
Cogmedix Executive Vice President and General Manager, Matt Giza, shared Marshall’s enthusiasm. “Cogmedix is very excited to be a part of the impact AsepticSure® will have across the globe. The need for this technology extends well beyond hospitals. We are thrilled to be a key part of its commercialization.”
Units manufactured by Cogmedix will meet the growing demand for greater than 6-log (>99.9999%) disinfection in hospital rooms and other critical infrastructure across the globe.
The AsepticSure® process demonstrates a previously unobtainable level of hospital room disinfection within normal workflows while demonstrating immediate and dramatic reductions in new hospital- associated infection rates. AsepticSure® is the only hospital disinfection system that can guarantee a kill of infective pathogens, both bacterial and viral, of greater than 6-log (>99.9999%) throughout the entire room, and can independently verify it using the same FDA recommended testing products used to confirm surgical instrument sterilization in autoclaves.